Skip to main content

Peer Review reports

From: Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis

Original Submission
7 Apr 2023 Submitted Original manuscript
25 Jul 2023 Reviewed Reviewer Report
10 Nov 2023 Reviewed Reviewer Report
28 Nov 2023 Author responded Author comments - Guanghai Dai
Resubmission - Version 2
28 Nov 2023 Submitted Manuscript version 2
29 Nov 2023 Author responded Author comments - Guanghai Dai
Resubmission - Version 3
29 Nov 2023 Submitted Manuscript version 3
Publishing
3 Dec 2023 Editorially accepted
6 Dec 2023 Article published 10.1186/s12885-023-11709-1

You can find further information about peer review here.

Back to article page